Antibiotic resistance (AR) poses a significant and multifaceted global threat, demanding an interdisciplinary approach for effective mitigation.  The rise of resistant pathogens, driven by factors like overuse and misuse of antibiotics in human and veterinary medicine, and agricultural practices, necessitates collaboration across scientific disciplines.  Microbiology plays a central role in understanding resistance mechanisms, including genetic mutations, horizontal gene transfer, and biofilm formation.  Epidemiology tracks the spread of resistant strains and identifies high-risk populations and geographical areas, informing public health interventions.  Furthermore, pharmaceutical research is crucial in developing novel antibiotics and alternative therapies, such as bacteriophages and antimicrobial peptides.  However, AR's impact extends beyond the biomedical sphere.  Economically, it threatens healthcare systems through increased treatment costs and prolonged hospital stays.  Socially, AR undermines public health security, impacting equitable access to effective treatments and raising ethical concerns surrounding resource allocation.  Therefore, effective AR management necessitates a collaborative effort integrating microbiology, epidemiology, pharmacology, economics, and sociology to address this complex global challenge, promoting responsible antibiotic stewardship and fostering innovation in prevention and treatment strategies.